The AI workspace for legal professionals
- Legal research with access to more than 1 million sources
- Document automation
- Matter management
- Hosted in the EU and Switzerland
Try it free for 14 days (10 questions/day during trial)
The AI workspace for legal professionals
Try it free for 14 days (10 questions/day during trial)
25-1117•Allele Biotechnology and Pharmaceuticals, Inc. v. Regeneron Pharmaceuticals, Inc.
25-1117Court of Appeals for the Federal CircuitDec 31, 2024
NOTE: This order is nonprecedential.
United States Court of Appeals
for the Federal Circuit
______________________
ALLELE BIOTECHNOLOGY AND
PHARMACEUTICALS, INC.,
Plaintiff-Appellee
v.
REGENERON PHARMACEUTICALS, INC.,
Defendant-Appellant
______________________
2025-1117
______________________
Appeal from the United States District Court for the
Southern District of New York in No. 7:20-cv-08255-PMH,
Judge Philip M. Halpern.
______________________
O R D E R
The parties having so agreed, it is ordered that:
(1) The proceeding is DISMISSED under Fed. R. App.
P. 42 (b).
Case: 25-1117 Document: 13 Page: 1 Filed: 12/31/2024
-- 1 of 2 --
ALLELE BIOTECHNOLOGY AND PHARMACEUTICALS, I NC. V.
REGENERON PHARMACEUTICALS, I NC.
2
(2) Each side shall bear their own costs.
FOR THE COURT
December 31, 2024
Date
ISSUED AS A MANDATE: December 31, 2024
Case: 25-1117 Document: 13 Page: 2 Filed: 12/31/2024
-- 2 of 2 --
Connect Omnilex to search the legal corpus from your AI assistant.